Bharat Biotech on Friday announced that it has terminated its agreement with Brazil's Precisa Medicamentos and Envixia Pharmaceuticals for Covaxin. The company said it'll continue to work with Brazil's healthcare authority ANVISA to get all required approvals for Covaxin's use there. This comes after the Brazilian government suspended a deal to buy 20 million vaccine doses over corruption charges.